Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

ANTH 4.47 0.00 (0.00%)
price chart
Anthera Pharmaceuticals PT Raised to $7.50 at Piper Jaffray (ANTH)
Research analysts at Piper Jaffray increased their price target on shares of Anthera Pharmaceuticals (NASDAQ:ANTH) to $7.50 in a report released on Monday.
Morning Watch List: Ford Motor Company (NYSE:F), Anthera Pharmaceuticals ...  Property Mentor
Drowning Stocks Update - Anthera Pharmaceuticals Inc (NASDAQ:ANTH ...
On Monday, Following U.S. Stocks were among the �Top Losers�: Anthera Pharmaceuticals Inc (NASDAQ:ANTH), NTELOS Holdings Corp (NASDAQ:NTLS), Axion Power International, Inc. (NASDAQ:AXPW), Seventy Seven Energy Inc (NYSE:SSE).
Anthera Pharmaceuticals, Inc. Short Interest Disclosure
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) reported a rise of 46.2% or 380,967 shares in its short interest. The short figure came in at 5.8% of the total floats.
First Call Rating Update on Anthera Pharmaceuticals, Inc.
According to First Call, Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) is a stock to Hold. The firm is of the view that investors may remain invested in the counter, unless advised otherwise.
Company Shares of Anthera Pharmaceuticals, Inc. Rally 21.19%  Ashburn Daily
Anthera (ANTH) Drops 8% On StreetSweeper Cautious Article  Wall Street Pit
Anthera Pharmaceuticals Inc Analyst Rating Update
Analysts at Zacks have given a Neutral rating on Anthera Pharmaceuticals Inc (NASDAQ:ANTH) with a rank of 3. The counter has received an average rating of 1 from 2 brokerage firms.
Anthera Pharmaceuticals Inc Price Target Update  Bar and Graph Report
Anthera Pharmaceuticals to Present at Cowen & Co. Healthcare Conference  MarketWatch
Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase ...
HAYWARD, Calif., March 16, 2015 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. ANTH, +3.70% in collaboration with its partner Zenyaku Kogyo Co.
Anthera Pharmaceuticals's Buy Rating Reaffirmed at Jefferies Group (ANTH)  The Legacy
Most Volatile Stocks: Anthera Pharmaceuticals, Inc. (ANTH), Reis, Inc. (REIS ...
Anthera Pharmaceuticals, Inc. (ANTH) of the Healthcare sector has gained 0.22% from opening today with a volume of 85,484 shares and volatility of 12.76%.
Anthera Pharmaceuticals Given New $7.50 Price Target at Piper Jaffray (ANTH)  WKRB News
Anthera Pharmaceuticals Price Target Increased to $7.50 by Analysts at Piper ...  Mideast Time
Anthera Pharmaceuticals Announces Completion of Public Offering of Common ...
HAYWARD, Calif., March 23, 2015 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of 5,555,556 shares of its common stock, offered at a price of ...
Anthera Pharmaceuticals Inc. Files SEC Form SC 13G, Statement of Acquisition ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Worth-Watching U.S. Stocks Alert: Anthera Pharmaceuticals Inc (NASDAQ:ANTH ...
Anthera Pharmaceuticals, Inc. (ANTH), declared that Paul F. Truex, President and Chief Executive Officer, presented a corporate update on the progress of the Corporation's development programs at the 35th Annual Cowen & Corporation Health Care ...